Arkolith/Insider Trading/ATRC/Form 4

Doraiswamy Vinayak

Chief Scientific OfficerAtriCure, Inc. (ATRC) · full profile →Form 4 · filed Mar 3, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 1, 2026Grant(A)30K—$0102K
Mar 1, 2026Grant(A)15K—$0117K
Mar 1, 2026Tax withholding(F)16K$31.26$487K102K

Transaction Codes

A
Grant / award
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001862458-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML